GUTS insider trading
NasdaqGM HealthcareFRACTYL HEALTH, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About FRACTYL HEALTH, INC.
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Company website: fractyl.com
GUTS insider activity at a glance
FilingIQ has scored 63 insider transactions for GUTS since Feb 6, 2024. The most recent filing in our index is dated Jun 10, 2026.
Across the full history, 14 open-market purchases
and 7 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on GUTS insider trades is 57.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest GUTS Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for GUTS?
- FilingIQ tracks 63 Form 4 insider transactions for GUTS (FRACTYL HEALTH, INC.), covering filings from Feb 6, 2024 onwards. 12 of those were filed in the last 90 days.
- Are GUTS insiders net buyers or net sellers?
- Across the full Form 4 history for GUTS, 14 transactions (22%) were open-market purchases and 7 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does GUTS insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is GUTS in?
- FRACTYL HEALTH, INC. (GUTS) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $74.89M.
Methodology & sources
Every GUTS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.